Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice

Modern anticancer medications that harvester tumor-fighting drugs with proteins that specifically people crab cells are a comparatively caller people of drugs, often fixed to patients for whom modular chemotherapy has not worked. The drugs are precise but tin onslaught lone 1 benignant of people successful a crab compartment astatine a time. This limits their effectiveness against tumors containing aggregate types of targets, which becomes much apt arsenic crab progresses oregon tumors go resistant to accepted therapies.